Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience | Zendy

Jennifer Furin | Zendy; Medea Gegia | Zendy; Carole D. Mitnick | Zendy; Michael Rich | Zendy; Sonya Shin | Zendy; Mercedes C. Becerra | Zendy; Peter Drobac | Zendy; Paul Farmer | Zendy; Rocio Hurtado | Zendy; Jacob Joseph | Zendy; Salmaan Keshavjee | Zendy; Iagor Kalandadze | Zendy

Open Access

Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience

Author(s) -

Jennifer Furin,

Medea Gegia,

Carole D. Mitnick,

Michael Rich,

Sonya Shin,

Mercedes C. Becerra,

Peter Drobac,

Paul Farmer,

Rocio Hurtado,

Jacob Joseph,

Salmaan Keshavjee,

Iagor Kalandadze

Publication year - 2011

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.11.092320

Subject(s) - medicine , tuberculosis , regimen , streptomycin , family medicine , population , pediatrics , surgery , environmental health , antibiotics , pathology , microbiology and biotechnology , biology

The category II retreatment regimen for management of tuberculosis in previously treated patients was first introduced in the early 1990s. It consists of 8 months of total therapy with the addition of streptomycin to standard first-line medications. A review of 6500 patients on category II therapy in Georgia showed poor outcomes and high rates of streptomycin resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research